RPS6KA3 Gene Mental Retardation X-linked Type 19 Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for RPS6KA3 Gene Mental Retardation, X-linked type 19 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RPS6KA3 Gene Mental Retardation, X-linked type 19.
Test Details
The RPS6KA3 gene is associated with a condition called mental retardation, X-linked type 19 (MRX19). This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the RPS6KA3 gene to detect any mutations or variations that may be responsible for MRX19.
Mental retardation, X-linked type 19 is a genetic disorder that primarily affects males. It is characterized by intellectual disability, delayed speech and language development, behavioral problems, and some physical abnormalities. The severity of symptoms can vary widely among affected individuals.
NGS is a high-throughput DNA sequencing method that allows for the analysis of multiple genes simultaneously. It can detect a wide range of genetic variations, including point mutations, insertions, deletions, and rearrangements. By sequencing the RPS6KA3 gene, this test can identify any genetic changes that may be causing MRX19.
The results of the NGS genetic test can help in confirming a diagnosis of MRX19 and provide valuable information for genetic counseling and family planning. It can also aid in the development of personalized treatment plans and management strategies for individuals with MRX19.
Test Name | RPS6KA3 Gene Mental retardation X-linked type 19 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for RPS6KA3 Gene Mental retardation, X-linked type 19 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RPS6KA3 Gene Mental retardation, X-linked type 19 |
Test Details | The RPS6KA3 gene is associated with a condition called mental retardation, X-linked type 19 (MRX19). This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the RPS6KA3 gene to detect any mutations or variations that may be responsible for MRX19. Mental retardation, X-linked type 19 is a genetic disorder that primarily affects males. It is characterized by intellectual disability, delayed speech and language development, behavioral problems, and some physical abnormalities. The severity of symptoms can vary widely among affected individuals. NGS is a high-throughput DNA sequencing method that allows for the analysis of multiple genes simultaneously. It can detect a wide range of genetic variations, including point mutations, insertions, deletions, and rearrangements. By sequencing the RPS6KA3 gene, this test can identify any genetic changes that may be causing MRX19. The results of the NGS genetic test can help in confirming a diagnosis of MRX19 and provide valuable information for genetic counseling and family planning. It can also aid in the development of personalized treatment plans and management strategies for individuals with MRX19. |